Industry Updates

First OMCL analytical procedures for determination of nitrosamine drug substance-related impurities (NDSRIs) and intermediate-related contaminants published

Domestic Pharmaceutical Companies Accelerating Innovation and Transformation to Create New Quality Productivity

Concept Paper on the revision of Annex 11 of the guidelines on Good Manufacturing Practice for medicinal products – Computerised Systems

Service Hotline

0762-7931111

Follow Us

About TITAN: Introduction to TITAN; Corporate Culture; Corporate History; Sustainable Development

News: News about Titan; Industry Updates; Policies and Regulations; Public Information

Products and Services: Product Center; Customer Service

R&D and Quality: Quality System; Certification and Qualification; Research Center

Talent Development: Talent Philosophy; Recruitment

Contact Us: Contact Information; Message and Feedback

2026 ® Copyright：Titan Pharmaceutical Co., Ltd. (Guangdong)

粤公网安备44162102000163 粤ICP备81102905号-1 (Yue)-Non operational -2022-0065

TOP

365英国上市·(集团)有限公司-官方网站主页